AA
LRCX icon

Altrafin AG’s Lam Research LRCX Stock Holding History

Altrafin AG’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-112,090
Closed -$4.1M – 75
2022
Q3 		$4.1M Buy
112,090
+2,350
+2% +$105K 2.46% 15
2022
Q2 		$4.68M Buy
109,740
+9,750
+10% +$464K 2.52% 11
2022
Q1 		$5.38M Buy
99,990
+8,860
+10% +$516K 2.11% 17
2021
Q4 		$6.55M Buy
+91,130
New +$5.71M 2.37% 13

Other funds holding LRCX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altrafin AG's LRCX Position: Q4 2022 in Review

Altrafin AG sold out of Lam Research (LRCX) in Q4 2022, closing a stake of 112,090 shares — an estimated $4.1M sold.

Altrafin AG first reported a position in LRCX in Q4 2021 and held it in 4 quarters. The position peaked at $6.55M in Q4 2021. 1,346 funds tracked by Wall St. Rank hold LRCX as of Q4 2022.

  • Altrafin AG reported no remaining Lam Research position as of Q4 2022 after selling out during the quarter.
  • Altrafin AG sold 112,090 Lam Research shares in Q4 2022, an estimated $4.1M.
  • Altrafin AG first reported a position in Lam Research in Q4 2021 and held it in 4 quarters.
  • Altrafin AG's Lam Research position peaked at $6.55M in Q4 2021.
  • 1,346 funds tracked by Wall St. Rank held Lam Research as of Q4 2022.

Based on Altrafin AG's 13F filing for Q4 2022, filed 17 Feb 2026.